Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative User Experiences With BD Nano™ PRO 32G Extra Thin Wall Pen Needle vs the Terumo Nanopass® 34G Pen Needle

NCT03878745 is registered in ClinicalTrials.gov with Becton, Dickinson and Company as lead sponsor.

NCT NCT03878745
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03878745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative User Experiences With BD Nano™ PRO 32G Extra Thin Wall Pen Needle vs the Terumo Nanopass® 34G Pen Needle
Lead sponsor
Becton, Dickinson and Company
Phase
Not applicable
Overall status
Completed
Start date
February 11, 2019
Completion date
June 14, 2019
Enrollment
55 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes